| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2917203 | Heart, Lung and Circulation | 2014 | 4 Pages |
Abstract
Pulmonary arterial hypertension (PAH) is an infrequent but nevertheless serious life threatening severe complication of human immunodeficiency virus (HIV) infection. In today's era of antiretroviral therapy (ART), the mortality of HIV patients has greatly reduced due to improved immune function and fewer opportunistic infections. However, these patients have an increased incidence of PAH. In this review, we will mainly discuss HIV-related pulmonary arterial hypertension (HRPH) in terms of the epidemiology, pathogenesis, clinical characteristics and treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hai-Long Dai, Ming Zhang, Zhi-Cheng Xiao, Xue-Feng Guang, Xiao-Long Yin,